Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

5 May 2010

Myriad Genetics' third-quarter fiscal 2010 revenues increase 5% to $90.8M

Myriad Genetics, Inc. today reported financial results for the third fiscal quarter and the nine-month period ended March 31, 2010.

5 May 2010

Fudged cancer patient waiting times reports, says AMAQ

The Australian Medical Association of Queensland (AMAQ) recently revealed that the state’s health authorities are keeping the truth about waiting time for cancer patients under wraps.

4 May 2010

BSD Medical to sell 1,644,737 common stock shares in registered direct offering

BSD Medical Corporation today announced that it entered into a securities purchase agreement with two institutional investors for the sale of 1,644,737 shares of its common stock in a registered direct offering at $1.52 per share. In addition, warrants to purchase 1,233,553 shares of common stock in the aggregate will be issued to the investors.

3 May 2010

RaySearch Laboratories restructures license agreement with Varian Medical Systems

RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.

3 May 2010

Results from VeriStrat biomarker analysis of Phase III trial presented at European Lung Cancer Conference

Results from the VeriStrat biomarker analysis of a multicenter Phase III trial were presented today at the 2nd European Lung Cancer Conference currently being held in Geneva, Switzerland. Results showed that the VeriStrat test identified patients who were likely to have a survival benefit from treatment with erlotinib, a commonly prescribed oral therapy for advanced non-small cell lung cancer.

3 May 2010

Smoking can increase risk of second cancer in breast cancer survivors

Women who survive early-stage breast cancer and smoke have an increased chance of developing a new second cancer in their other breast or elsewhere.

3 May 2010

CTCA installs Calypso's real-time tumor tracking technology at Southwestern Regional Medical Center

Calypso Medical Technologies, Inc., a developer of non-ionizing real-time localization technology used for the precise tracking of tumor targets, and Cancer Treatment Centers of America, a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment, announced today that with the installation of the Calypso System at the CTCA at Southwestern Regional Medical Center in Tulsa, Okla., Calypso's real-time tumor tracking technology is now available at all CTCA centers nationwide.

30 Apr 2010

Elekta Neuromag tool to be highlighted at AANS 2010 Annual Meeting

At the 2010 American Association of Neurological Surgeons Annual Meeting, May 1-5 at the Pennsylvania Convention Center, Elekta will host a series of presentations highlighting Elekta Neuromag, a tool that measures and records brain activity using magnetoencephalography technology.

From Elekta 30 Apr 2010

Removing unruptured AVM decreases risk of hemorrhaging, provides better outcomes to patients

Individuals diagnosed with a brain arteriovenous malformation, an abnormal tangle of arteries and veins, are at an increased risk of vessel rupture and bleeding that can cause stroke and permanent brain damage.

29 Apr 2010

Oncology unit of Jewish General Hospital focuses on Smart for Life cookies

Smart for Life cookies will be the focus of a study in the oncology unit of the Jewish General Hospital, acknowledged as a world leader in many fields of investigation and a key teaching site for McGill University.

29 Apr 2010

CINJ trial targets new combination therapy for advanced solid tumors

Building off recent laboratory discoveries relating to how cancer cells become resistant to therapies that attempt to starve cancer, scientists at The Cancer Institute of New Jersey (CINJ) are now applying that knowledge to a process in which cancer cells eat themselves to downsize and resist therapy. The ultimate goal of this effort is to improve upon current anticancer treatments.

29 Apr 2010

New report evaluating use of SBRT in lung cancer treatment released

The American Society for Radiation Oncology has released its Emerging Technology Committee's report evaluating the use of stereotactic body radiotherapy in lung cancer treatment.

29 Apr 2010

SBRT shows promise in treatment of lung, liver and spinal tumors: Clinical experts

Radiosurgical approaches to cancer treatment are showing promise in the treatment of lung, liver, and spinal tumors, according to four leading clinical experts who presented at a symposium in New York earlier this month.

28 Apr 2010

Head- and neck-cancer patients who continue to smoke during radiation therapy have poorer overall survival

Smokers who don't quit before radiation therapy for throat, mouth and other head and neck cancers fair significantly worse than those who do, research from the UC Davis Cancer Center has found.

28 Apr 2010

Melanin-covered nanoparticles may protect bone marrow from harmful radiation therapy effects: Research

Tiny, melanin-covered nanoparticles may protect bone marrow from the harmful effects of radiation therapy, according to scientists at Albert Einstein College of Medicine of Yeshiva University who successfully tested the strategy in mouse models.

27 Apr 2010

Vitamin selected as agency of record for IZI Medical Products

The boutique design-web-public relations firm Vitamin® announced today its selection as agency of record for IZI Medical Products, a Maryland-based innovator of medical device accessories. Vitamin is providing IZI with retained public relations services for strengthening overall brand and key product awareness. Additionally, Vitamin is handling product naming and product branding, as well as integrated marketing for refreshing IZI's new corporate messaging, tagline and logo.

26 Apr 2010

Karolinska University Hospital acquires Leksell Gamma Knife Perfexion fifth generation radiosurgery system

Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife® surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife® Perfexion™.

24 Apr 2010

Karolinska University Hospital acquires Elekta's fifth generation radiosurgery system

Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.

24 Apr 2010

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

BSD Medical Corporation today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with chemotherapy has the potential to improve control rate and long-term survival for the treatment of children with high-risk cancer who have a dismal prognosis.

23 Apr 2010

Radiation Therapy News and Research

Further Reading

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

Myriad Genetics' third-quarter fiscal 2010 revenues increase 5% to $90.8M

Fudged cancer patient waiting times reports, says AMAQ

BSD Medical to sell 1,644,737 common stock shares in registered direct offering

RaySearch Laboratories restructures license agreement with Varian Medical Systems

Results from VeriStrat biomarker analysis of Phase III trial presented at European Lung Cancer Conference

Smoking can increase risk of second cancer in breast cancer survivors

CTCA installs Calypso's real-time tumor tracking technology at Southwestern Regional Medical Center

Elekta Neuromag tool to be highlighted at AANS 2010 Annual Meeting

Removing unruptured AVM decreases risk of hemorrhaging, provides better outcomes to patients

Oncology unit of Jewish General Hospital focuses on Smart for Life cookies

CINJ trial targets new combination therapy for advanced solid tumors

New report evaluating use of SBRT in lung cancer treatment released

SBRT shows promise in treatment of lung, liver and spinal tumors: Clinical experts

Head- and neck-cancer patients who continue to smoke during radiation therapy have poorer overall survival

Melanin-covered nanoparticles may protect bone marrow from harmful radiation therapy effects: Research

Vitamin selected as agency of record for IZI Medical Products

Karolinska University Hospital acquires Leksell Gamma Knife Perfexion fifth generation radiosurgery system

Karolinska University Hospital acquires Elekta's fifth generation radiosurgery system

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News